Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Robert Brodell MD, FAAD
Robert T. Brodell MD, FAAD Editor-in-Chief
Sarah Chamlin MD
Sarah L. Chamlin MD Advisory Board
Christen Mowad MD
Christen Maria Mowad MD Advisory Board
See All Experts
featured
Published in Dermatology

Expert Opinion / Interview · August 18, 2014

Monitoring Patients at High Risk for Developing Cutaneous Melanoma—Part 3: Monitoring Frequency for Atypical and Prominent Numbers of Pigmented Lesions

Tony Nimeh MD
Interview by
Tony Nimeh MD
Arthur Rhodes MD, MPH

 

 Save  Recommend
 Share

Additional Info

  1. Duggleby WF, Stoll H, Priore RL, et al. A genetic analysis of melanoma--polygenic inheritance as a threshold trait. Am J Epidemiol. 1981;114(1):63-72.

  2. Lookingbill DP. Yield from a complete skin examination. Findings in 1157 new dermatology patients. J Am Acad Dermatol. 1988;18(1 Pt 1):31-37.

  3. Goldberg MS, Doucette JT, Lim HW, et al. Risk factors for presumptive melanoma in skin cancer screening: American Academy of Dermatology National Melanoma/Skin Cancer Screening Program experience 2001-2005. J Am Acad Dermatol. 2007;57(1):60-66.
  4. Sepehr A, Chao E, Trefrey B, et al. Long-term outcome of Spitz-Type melanocytic tumors. Arch Dermatol 2011;147(10):1173-1179.

Further Reading

Most Read This Week

Recently Updated